| EU paediatric MOG consortium consensus: Part 5–Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders AL Bruijstens, EM Wendel, C Lechner, F Bartels, C Finke, M Breu, ... European Journal of Paediatric Neurology 29, 41-53, 2020 | 87 | 2020 |
| Neuronal autoantibodies associated with cognitive impairment in melanoma patients F Bartels, T Strönisch, K Farmer, K Rentzsch, F Kiecker, C Finke Annals of Oncology 30 (5), 823-829, 2019 | 57 | 2019 |
| EU paediatric MOG consortium consensus: Part 2–Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders M Baumann, F Bartels, C Finke, C Adamsbaum, Y Hacohen, K Rostásy, ... European Journal of Paediatric Neurology 29, 14-21, 2020 | 49 | 2020 |
| Clinical and magnetic resonance imaging outcome predictors in pediatric anti–N‐methyl‐D‐aspartate receptor encephalitis F Bartels, S Krohn, M Nikolaus, J Johannsen, R Wickström, M Schimmel, ... Annals of Neurology 88 (1), 148-159, 2020 | 39 | 2020 |
| Clinical and neuroimaging findings in MOGAD–MRI and OCT F Bartels, A Lu, FC Oertel, C Finke, F Paul, C Chien Clinical & Experimental Immunology 206 (3), 266-281, 2021 | 38 | 2021 |
| Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure F Bartels, K Nobis, G Cooper, E Wendel, R Cleaveland, B Bajer-Kornek, ... Multiple Sclerosis Journal 25 (7), 927-936, 2019 | 37 | 2019 |
| High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients C Finke, F Bartels, A Lütt, H Prüss, L Harms Journal of neurology 264, 1968-1977, 2017 | 33 | 2017 |
| EU paediatric MOG consortium consensus: Part 3–Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders T Armangue, M Capobianco, A de Chalus, G Laetitia, K Deiva, ... European Journal of Paediatric Neurology 29, 22-31, 2020 | 24 | 2020 |
| Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events L Müller-Jensen, S Knauss, L Ginesta-Roque, S Christian, S Maierhof, ... Frontiers in Immunology 14, 423, 2023 | 23 | 2023 |
| Anti-ARHGAP26 autoantibodies are associated with isolated cognitive impairment F Bartels, H Prüss, C Finke Frontiers in Neurology 9, 656, 2018 | 21 | 2018 |
| Association between neuronal autoantibodies and cognitive impairment in patients with lung cancer F Bartels, MM Wandrey, A Aigner, T Strönisch, K Farmer, K Rentzsch, ... JAMA oncology 7 (9), 1302-1310, 2021 | 20 | 2021 |
| LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance A Berberich, F Bartels, Z Tang, M Knoll, S Pusch, N Hucke, T Kessler, ... Frontiers in oncology 10, 747, 2020 | 20 | 2020 |
| Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR Encephalitis M Nikolaus, P Rausch, K Rostásy, A Bertolini, R Wickström, J Johannsen, ... Neurology-Neuroimmunology Neuroinflammation 10 (3), 2023 | 5 | 2023 |
| Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis F Bartels, B Baumgartner, A Aigner, G Cooper, A Blaschek, EM Wendel, ... Neurology-Neuroimmunology Neuroinflammation 10 (2), 2023 | 5 | 2023 |
| Severe Hippocampal Atrophy in a Patient With Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy F Bartels, J Heine, C Finke JAMA neurology, 2023 | 1 | 2023 |
Carsten FinkeHeisenberg Professor and Consultant Neurologist, Dept. of Neurology, Charité - Universitätsmedizin在 charite.de 的电子邮件经过验证
